Related Experiment Video

Updated: Aug 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Lipoid pneumonia: a preventable complication

Eyal Meltzer1, Larissa Guranda, Lubov Vassilenko

  • 1Department of Internal Medicine, Sheba Medical Center, Tel Hashomer, Israel. emeltzer@post.tau.ac.il

The Israel Medical Association Journal : IMAJ
|February 3, 2006
PubMed
Abstract

Insights

Lipoid pneumonia (LP) is an underdiagnosed lung condition caused by lipid aspiration, often linked to mineral oil laxatives. Early diagnosis and discontinuing the oil can resolve symptoms, highlighting the need for increased physician awareness.

Area of Science:

  • Pulmonology
  • Radiology
  • Pathology

Background:

  • Lipoid pneumonia (LP) is a rare lung inflammation caused by lipid aspiration.
  • It is frequently associated with the use of mineral oil as a laxative.
  • LP is often underdiagnosed due to limited clinician familiarity.

Observation:

  • Two elderly patients with neurological conditions and aspiration risk developed LP.
  • Both cases were linked to mineral oil laxative use.
  • Symptoms persisted for months before diagnosis and resolved after discontinuing mineral oil.

Findings:

  • Computed tomography showed bilateral low attenuation infiltrates with a "crazy paving" pattern in one case.
  • Sudan Black staining confirmed lipid-laden macrophages in transbronchial biopsy and sputum cytology.
  • Elderly patients with aspiration risk are particularly susceptible to LP.

Implications:

  • Increased physician awareness is crucial for timely diagnosis and prevention of lipoid pneumonia.
  • Primary prevention strategies, including potential changes to mineral oil licensing, are indicated.
  • Prompt diagnosis and cessation of causative agents like mineral oil can lead to symptom resolution.

More Related Videos

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...